SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, ~~D.C.~~DC 20549

FORM 8-K

~~Current~~CURRENT ~~Report Pursuant to Section 13 or~~REPORT

Pursuant to Section 13 or 15(d) of the ~~Securities Act of 1934~~

~~Date~~Securities ofExchange ~~Report~~Act ~~(Date~~ of ~~earliest event reported):~~1934

~~October~~Date 18of Report (Date of earliest event reported): May 14, ~~2011~~2012

~~CHINA~~SURGLINE ~~NUVO SOLAR ENERGY~~INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter)

(Exact Name of Registrant as Specified in Charter)

NEVADA		333-48746		87-0567853
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Nevada	333-48746	87-0567853
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

___ 319 Clematis Street, Suite 400, West Palm Beach, Florida 33401___
(Address Of Principal Executive Offices) (Zip Code)

~~319~~Registrant’s ~~Clematis~~Telephone ~~Street~~Number, ~~Suite~~Including Area ~~703~~Code (561) 514-9042

~~West~~Check ~~Palm~~the ~~Beach,~~appropriate ~~Florida~~box ~~33401~~below if the Form 8-K is intended to simultaneously ~~(Address~~satisfy the filing obligation of ~~Principal~~the ~~Executive~~registrant ~~Offices,~~under ~~Zip~~any ~~Code)~~of the following provisions:

~~Registrant’s~~ ~~telephone~~Written ~~number,~~communications ~~including~~pursuant ~~area~~to ~~code:~~ Rule 425 under the Securities Act (~~561~~17 CFR 230.425) ~~514~~ Soliciting material pursuant to Rule 14a-~~9042~~12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~(Former~~Item ~~name~~1.01 orEntry ~~former~~into ~~address,~~a ifMaterial ~~changed~~Definitive ~~since last report~~Agreement.)

~~Check~~On May 14, 2012, the ~~appropriate~~Registrant ~~box~~entered ~~below~~into and ifconsummated the ~~Form~~Agreement ~~8-K~~Concerning ~~filing~~that isExchange ~~intended~~of toSecurities ~~simultaneously~~(the ~~satisfy~~“Agreement”) ~~the~~with ~~filing~~Eden ~~obligation~~Surgical ofTechnologies, LLC ~~the~~(“Eden”), ~~registrant~~a ~~under~~Texas ~~any~~limited ofliability company and the ~~following~~equity ~~provisions:~~holders of Eden.

~~. Written~~Pursuant ~~communications~~to ~~pursuant~~the Agreement, the Registrant agreed to ~~Rule~~acquire ~~425~~all ~~under~~of the ~~Securities~~outstanding ~~Act~~membership interests of Eden in exchange (17the ~~CFR~~“Exchange”) ~~230~~for the issuance of an aggregate of 50,000,000 shares (the “Exchange Shares”) of the Registrant’s common stock, par value $0.~~425~~001 per share (the “Common Stock”). As a result of the Exchange, Eden became a wholly-owned subsidiary of the Registrant. The parties have taken the actions necessary to provide that the Exchange is treated as a “tax free exchange” under Section 368 of the Internal Revenue Code of 1986, as amended.

~~. Soliciting~~Eden ~~material~~is ~~pursuant~~an toimporter ~~Rule~~and ~~14a-12~~distributor ~~under~~of ~~the~~trauma surgical ~~Exchange Act (17 CFR 240.14a-12)~~products

Item 3. ~~Pre-commencement~~02 ~~communications~~Unregistered ~~pursuant~~Sales toof ~~Rule~~Equity ~~14d-2(b) under the Exchange Act (17 CFR 240~~Securities.~~14d-2(b))~~

The securities described in Item 1. ~~Pre-commencement~~01 ~~communications~~above were offered and sold in reliance upon exemptions from registration pursuant to ~~Rule~~Section ~~13e-~~4(c2) under the ~~Exchange~~Securities Act. ~~(17~~At ~~CFR~~the ~~240~~time of their issuance, the securities will be deemed to be restricted securities for purposes of the Securities Act, and the certificates representing the securities shall bear legends to that effect.~~13e-4(c))~~ The securities may not be resold or offered in the United States without registration or an exemption from registration.

Item 59.0301 Financial Statements and Exhibits.

~~AMENDMENTS~~(a) Financial statements: TOAs ~~ARTICLES~~a OFresult ~~INCORPORATION~~of ORthe ~~BYLAWS;~~Exchange ~~CHANGES~~described INin ~~FISCAL~~Item ~~YEAR~~1.01, the Registrant will file the audited financial information and the notes thereto in an amendment to this Form 8-K within the time proscribed.

(b) Pro forma financial information: As a result of the Exchange described in Item 1.01, the Registrant will file the pro forma financial information and the notes thereto in an amendment to this Form 8-K within the time proscribed.

~~On October 18, 2011, Amended and Restated Articles of Incorporation~~ (~~the “Amendment”~~c) ~~was~~Shell ~~filed~~company ~~with~~transaction: ~~the~~This ~~Secretary~~section ofdoes ~~State~~not ~~of Nevada to change the name of the Company from China Nuvo Solar Energy, Inc~~apply. to SurgLine International, Inc. The Amendment was approved by a majority of the Company’s shareholders and the Company’s Board of Directors. The Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

(d) Exhibits: The disclosures set forth under Item 9.01. ~~Financial~~(a) ~~Statements~~ and ~~Exhibits~~(b) are incorporated by reference into this Item 9.01 (d).

~~(a)~~99.1 Press Release dated May 17, 2012

~~Not applicable.~~ SIGNATURES

~~(b)~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Not applicable.

	SURGLINE INTERNATIONAL, INC

Dated: May17, 2012	By:	/s/ Thomas G Toland
		Thomas G. Toland, Chief Executive Officer

(c)

Exhibit No.	Description
99.1	Press Release dated May 17, 2012

Not applicable.

(d)

Exhibits.

Exhibit	Description
3.1	Certificate of Amendment and Amended and Restated Articles of Incorporation (filed herewith)
99.1	Press Release, dated October 20, 2011

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SURGLINE INTERNATIONAL, INC. Date: October 20, 2011 By: /s/ Barry S. Hollander Barry Hollander, Principal Financial Officer

Filing Compare · SURGLINE INTERNATIONAL, INC.